Exane Asset Management Catalent, Inc. Transaction History

Exane Asset Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Sep 06, 2018	SELL	$38.72 - $42.52 $9.03 Million - $9.92 Million	-233,199 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$39.4 - $47.39 $70,013 - $84,212	1,777 Added 0.77%	233,199 $0
Q4 2017 Feb 08, 2018	BUY	$37.27 - $43.02 $8.63 Million - $9.96 Million	231,422	231,422 $0

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.